References
- Project Sphere-Office Health. Study on the consumption of the medicines in Italy. IMS; 2003.
- Signalings From The World Health Organization. The progress of the medicine threatened by the medicine-resis-tance. Pharmaco-Economy, Year V, (2001); n. 1: 5–6.
- Bassetti D. Criterions of choice of the antibacterial chemotherapy. In: Bassett D, eds. Anti-infectious Chemother. and their rational employment 2001; 18: 359–360.
- Graham Neil MH. Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract. PharmacoEconomics 1994; 5 (suppl. 2): 1-10.
- Chambers HF, Sande MA. Chemotherapy of infectious diseases. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Bases of Therapeutics. 9th ed. Tx, Usa. McGraw-Hill. 1997; 43: 1009–1018.
- IMS Health.
- Appel GB. Aminoglycoside nephrotoxicity: studies of the sites of nephron damage, The Aminoglycosides: Microbiology, Clinical use, and Toxicity, 1982; 269-282.
- Jawetz E. Antibiotic aminoglycosides and polymyxin. In: Katzung BG, ed. General Pharmacology and Clinic. Padova, Italy. Piccin. 1997; 45: 758–765.
- Capri S. The Pharmaco-Economy: methods of analysis. In: Clementi F, Fumagalli G, eds. Economy and Normative of the Medicine, 1998; 5: 53–67.
- L'Informatore Farmaceutico, Italian directory of medi-cines and manufacturers, OEMF, 2003; part I: 207-210.
- Gerald L, Mandell and Petri WA, Jr. Penicillins, cephalosporins and other beta-lactam antibiotics. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Bases of Therapeutics. 9th ed. Tx, Usa. McGraw-Hill. 1997; 46: 1058–1059.
- Falkow S, Mekalanos J. Entero-bacterias and Vibrio. In: Davis BD, Dulbecco R, Eisen HN, Ginsberg HS, eds. Microbiology. 4th ed. Bologna, Italy. Zanichelli. 1998; 27: 577–605.
- Bassett' D. Reasoned therapy of the Principal Infectious Syndromes. In: Bassett D, ed. Anti-infectious Chemotherapy and their rational employment. 7th ed. 2001; 19: 385–389.
- La Placa M. Synoptics Tables of Clinical Microbiology. In: La Placa M, ed. Principles of Medical Microbiology. Esculapio. Bologna, Italy. 2000; 714-719.
- Bassett' D. Beta-lactam. In: Bassett' D, ed. Anti-infec-tious Chemotherapy and their rational employment, 2001; 5: 86–120.
- Mandell G L, Petri WA, Jr. Sulphamidics, trimethoprim-sulfamethoxazole, quinolones and medicines for the infections of the tract urinary. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Bases of Therapeutics. 9th ed. Tx, USA. McGraw-Hill. 1997; 44: 1031–1044.
- Bassett' D. Various antibiotics. In: Bassett D, ed. Anti-infectious Chemotherapy and their rational employment, 2001; 15: 299–301.
- Hooper D C. The future of the quinolones, APUA (Alliance for the Prudent use of Antibiotics) Newsletter 2001, 19 (3).
- Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 2000; 133: 128–135.
- Office of Technology Assessment. Impacts of antibiotic-resistant bacteria. Washington DC: US Government Printing Office. Publication OTA-H-629; 1995.
- Carmeli Y, Troillet N, Karchmer AW, Samore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa, Arch Intern Med 1999; 159: 1127-1132.
- White VLC, Moore-Gillon L. Resources implication of patients with multidrug resistant tuberculosis, Thorax, 2000; 55: 962–963.
- L'Informatore Farmaceutico, Italian directory of medi-cines and manufacturers, OEMF, 2003; part III: 1581-1706.